MBP metabolic pharmaceuticals limited

METABOLIC PHARMACEUTICALS (MBP) up 13c to $1.65: Has risen five...

  1. 729 Posts.
    METABOLIC PHARMACEUTICALS (MBP) up 13c to $1.65: Has risen five
    days in a row for a total of 27c. Most recent report from the company
    was that 48 million shares held by Polychip Pharmaceuticals, a
    wholly-owned subsidiary of Circadian Technologies, will be released from
    escrow on October 23.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.